IS THE EFFECT OF HOMOEOPATHIC MEDICINE DIFFERENT FROM THE EFFECT OF PLACEBO IN HEALTHY INDIVIDUALS? – A RANDOMIZED, BLINDED, CONTROLLED, THREE ARMED HOMOEOPATHIC PATHOGENETIC TRIAL ON ELECTRO-PHOTONIC IMAGE CHANGES.

“A RANDOMISED, BLINDED, PLACEBO-CONTROLLED, THREE ARMED PARALLEL STUDY ON ELECTROPHOTONIC IMAGE CHANGES DURING HOMOEOPATHIC PATHOGENETIC TRIAL USING MOLECULAR AND ULTRA-MOLECULAR DOSES - A REPROVING OF BELLADONNA”
ABSTRACT:
Background:
Homoeopathic drug proving is the process of understanding the pathogenetic powers of the dynamised Homoeopathic drugs on healthy human beings. In homoeopathic drug proving due to the biomimicry of production of disease symptoms, there are tremendous chances for the altered electron communication which may produce changes in the Electro-photonic Emission. Although controversies exist on the action of Belladonna in the healthy human provers (Good year et al (1998), H. Wallah et al (2001), S Brien et al(2003)). This study takes up the challenge to re-evaluate the efficacy of Belladonna in homoeopathic pathogenetic trial in the molecular and ultra-molecular doses.
Method:
Randomised, blinded, placebo-controlled three-armed (Belladonna6C, Belladonna200C and Placebo) parallel study (n = 150) conducted in National Institute of Homoeopathy, India. The study design was framed as a four-week protocol consisting of Pre-Intervention period, Intervention Period, Post Intervention period for each participant. Primary and Secondary Outcome Measures are Twelve parameters of Electro Photonic Imaging [EPI] technique and Q-Form-02 (30 items, Likert scale questionnaire) respectively.
Result:
The analysis showed a statistically significant difference in eight parameters (P-value <0.05,) out of twelve parameters and the Form Coefficient parameter (P-value <0.001) revealed the effect of placebo during the run-in phase. The questionnaire Q-Form-02 analysis revealed a significant difference among the three groups. The post hoc analysis showed the number of symptoms and the scores among groups depicted the trend: Belladonna 6C > Belladonna 200C > Placebo.
Conclusion:
We may conclude that the Electro Photonic Emissions from the human body may serve as a parameter to differentiate the placebo effect from the Homoeopathic medicine effect in the Homoeopathic Pathogenetic Trial [Trial Registration: CTRI/ 2018/03/012290].

一项关于使用分子和超分子剂量进行同源性病理试验期间电光子图像变化的随机、盲法、安慰剂对照的三臂平行研究——对阿托品的再验证（A RANDOMISED, BLINDED, PLACEBO-CONTROLLED, THREE ARMED PARALLEL STUDY ON ELECTROPHOTONIC IMAGE CHANGES DURING HOMOEOPATHIC PATHOGENETIC TRIAL USING MOLECULAR AND ULTRA-MOLECULAR DOSES - A REPROVING OF BELLADONNA）

摘要：

背景：
同源性药物验证是理解动态同源性药物对健康人体病理作用力的过程。由于生产疾病症状的生物模拟性，同源性药物验证过程中存在巨大的电子通信改变的可能性，这可能导致电光子发射的变化。尽管关于阿托拉在健康人体验证者中的作用的争议存在（Good year et al (1998), H. Wallah et al (2001), S Brien et al(2003)）。本研究接受挑战，重新评估阿托拉在分子和超分子剂量同源性病理试验中的疗效。

方法：
在印度国家同源性学院进行的随机、盲法、安慰剂对照的三臂（阿托拉6C、阿托拉200C和安慰剂）平行研究（n = 150）。研究设计为四周协议，包括每个参与者的干预前、干预期和干预后期。主要和次要结果指标分别为电光子成像（EPI）技术的十二个参数和Q-Form-02（30项，李克特量表问卷）。

结果：
分析显示，在十二个参数中有八个参数（P值<0.05）存在统计学上的显著差异，形式系数参数（P值<0.001）揭示了安慰剂在运行阶段的影响。Q-Form-02问卷分析显示，三组之间存在显著差异。事后分析显示，症状数量和各组的评分趋势为：阿托拉6C > 阿托拉200C > 安慰剂。

结论：
我们可以得出结论，人体的电光子发射可能作为参数，区分同源性病理试验中的安慰剂效应与同源性药物效应[试验注册：CTRi/ 2018/03/012290]。